Dr. Donny Mehrabi, MD

Dr. Mehrabi practices at Bhskin Dermatology in Glendale, California.

Dr. Mehrabi's NPI, 1356454557, was assigned on August 15, 2006. Dr. Mehrabi graduated from Northeast Ohio Medical University in 2001. Dr. Mehrabi's California license number on file is A84588.

Dr. Mehrabi's primary practice is Bhskin Dermatology, at 1505 Wilson Ter Suite 240 Suite 240, Glendale, CA 91206-4033. The practice phone is (310) 205-3555.

Dr. Mehrabi's primary practice is Bhskin Dermatology in Glendale, California. The medical group on file is BHSkin Dermatology.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehrabi practices. Vendor and product names are available with a free account.

Dermatology is Dr. Mehrabi's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Mehrabi is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Mehrabi's licenses on file in 2 states: California and Texas.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, corns and calluses, itchy rashes, psoriasis and rash among the conditions Dr. Mehrabi treats.

CMS data shows 2,973 Medicare services from Dr. Mehrabi across 27 procedure codes in 2024, for 691 Medicare patients. Medicare paid $173,472 for them. Every service was in an office.

CMS counts 691 Medicare patients who saw Dr. Mehrabi in 2024. The largest group is 65 to 74, with 351 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mehrabi's median patient age at 47, with 55% women.

In 2024, Dr. Mehrabi wrote 1,066 Medicare Part D claims for 333 patients. 91% of them were for generic drugs. CMS names the drug for 921 of them, across 23 drugs with 11 or more claims each, at $195,990 in total drug cost. In 2023, CMS named 707 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Mehrabi for performance year 2024, reported as part of a group. Dr. Mehrabi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 321 procedures of removal or shaving of skin growth by Dr. Mehrabi, more than 93% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Mehrabi. Dr. Mehrabi has published most often in Dermatol Surg. Dr. Mehrabi's most frequent co-authors are Steven Richard Feldman, MD and Amit G. Pandya, MD.

Dmand AI links Dr. Mehrabi to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Non-alcoholic Fatty Liver Disease, Psoriasis and Fatty Liver. Open Payments lists research payments to Dr. Mehrabi that name 2 trials.

CMS Open Payments shows 913 general payments to Dr. Mehrabi from 48 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 56% of the total. Abbvie Inc. paid the most, $8,399. It also lists 5 research payments totaling $13,220 from 2018 to 2023, naming 2 clinical trials.

Dmand AI lists 2 awards for Dr. Mehrabi, most recently CMS Stage 1 EHR in 2013.

Dr. Mehrabi graduated from Northeast Ohio Medical University in 2001. Dr. Mehrabi is a member of AAD.

Dr. Mehrabi is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.